Compass Pathways controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
Controversy over psychedelic patents
Compass has been criticized for pursuing patents involving psychedelic compounds, treatment approaches, and certain psilocybin mushroom species. The controversy concerns whether broad intellectual-property rights could restrict research or privatize knowledge associated with naturally occurring psychedelics.